The Medical Peer-delivered Intervention of Brief Motivational Interviewing Via Instant Messaging Interaction in Reducing the Drug Abuse Among Youth in Hong Kong: A Randomized Controlled Trial
Sponsor study identifier
interventional
134
1 country
1
Study Start
March 1, 2021
Actual (reported)Primary Completion
August 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This is a two-arm, parallel-group, randomized controlled trial with an allocation ratio 1:1, by comparing the 12-month drug abuse reduction between the youth drug abusers who are individually randomized to participate in the intervention group receiving medical peer-delivered intervention of interactive brief motivational interviewing via instant messaging communication and those in the control group receiving general health information.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
December 11, 2020
Actual (reported)December 17, 2020
Actual (reported)March 1, 2021
Actual (reported)August 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Changes in drug consumption at 12 months comparing to that at baseline
The participants' changes in drug consumption between baseline and 12 months follow-up measured using a structured-questionnaire gathering the frequency and categoties of drug consumption in the past 30 days. The more frequencies and the more kinds of drug used indicating the higher consumption of drug abuse.
12 month
Changes in drug consumption at 6 month comparing to that at baseline
6 month
30 days self-reported drug abstinence at 6 months
6 month
30 days self-reported drug abstinence at 12 months
12 month
Changes in relapse risk among the quitters at 6 months comparing to that at baseline
6 month
Changes in relapse risk among the quitters at 12 months comparing to that at baseline
12 month
The interaction communication using brief motivational interviewing will be applied via the chatting function of instant messaging apps (e.g., WhatsApp, WeChat). The intervention will last for 6 month with a frequency of at least twice a week.
The subjects will receive general health information via SMS, such as "do physical exercise for at least 30 min per week will keep you healthy" for 6 month with a frequency of least twice a week.
Telephone peer counselling+referral to treatment if required+The interaction communication using brief motivational interviewing via the chatting function of instant messaging apps (e.g., WhatsApp, WeChat). The intervention will last for 6 month with a frequency of at least twice a week.
Telephone peer counselling+referral to treatment if required+general health information via SMS, such as "do physical exercise for at least 30 min per week will keep you healthy" for 6 month with a frequency of least twice a week.
The University of Hong Kong
Hong Kong, Hong Kong
Denise Shuk Ting Cheung, PhD
The University of Hong Kong
First Submitted
December 11, 2020
First Posted
December 17, 2020
Study Start
March 1, 2021
Actual (reported)Primary Completion
August 2022
Estimated (date passed)An Integrated Smoking Cessation and Alcohol Intervention Among Hong Kong Chinese Young People
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
May 4, 2022
Record last verified: 2022-04
The relevant anonymized patient-level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: